A recent molecular docking study documented that resveratrol could be effective against CRC by targeting NF-κB signaling [206], and in this regard, our group described resveratrol’s NF-κB suppression by resveratrol associated with an anti-inflammatory mode of action in CRC [207]. The gene discussed is NFKB1; the disease is colorectal carcinoma.